Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooué-Ivindo region, northeastern Gabon, 1997

Journal of Infectious Diseases

Volumn 191, Issue 6, 2005, Pages 964-968

  Heffernan, Richard T ^a,f   Pambo, Bertin ^b,g   Hatchett, Richard J ^c,h   Leman, Patricia A ^d   Swanepoel, Robert ^d   Ryder, Robert W ^a,e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Min of Health Republic of Gabon   (Gabon)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^e IL   (United States)

^f NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^g CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AFRICA; ANAMNESIS; ANTIBODY BLOOD LEVEL; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; VIRUS HEMORRHAGIC FEVER;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; EBOLAVIRUS; FEMALE; GABON; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 14844299763     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/427994     Document Type: Review

References (15)

1. Monath TP. Ecology of Marburg and Ebola viruses: speculations and directions for future research. J Infect Dis 1999; 179(Suppl 1):S127-38.
2. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 1999; 179(Suppl 1):S192-8.
3. Georges AJ, Leroy EM, Renaut AA, et al. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infect Dis 1999; 179(Suppl 1):S65-75.
4. Outbreak news. Wkly Epidemiol Rec 2001; 76:381-6.
5. Frankish H. Death toll continues to climb in Congo Ebola outbreak. Lancet 2003; 361:1020.
6. Georges-Courbot MC, Sanchez A, Lu CY, et al. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis 1997; 3:59-62.
7. Lahm SA. Ecology and economics of human/wildlife interaction in northeastern Gabon [PhD thesis]. New York: New York University, 1993.
8. Gonzalez JP, Nakoune E, Slenczka W, Vidal P, Morvan JM. Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic. Microbes Infect 2000; 2:39-44.
9. Busico KM, Marshall KL, Ksiazek TG, et al. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(Suppl 1):S102-7.
10. Leroy EM, Baize S, Volchkov VE, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000; 355:2210-5.
11. Johnson ED, Gonzalez JP, Georges A. Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa. Trans R Soc Trop Med Hyg 1993; 87:536-8.
12. Bouree P, Bergmann JF. Ebola virus infection in man: a serological and epidemiological survey in the Cameroons. Am J Trop Med Hyg 1983; 32:1465-6.
13. Dowell SF. Ebola hemorrhagic fever: why were children spared? Pediatr Infect Dis J 1996; 15:189-91.
14. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 1987; 155:437-44.
15. Johnson ED, Gonzalez JP, Georges A. Haemorrhagic fever virus activity in equatorial Africa: distribution and prevalence of filovirus reactive antibody in the Central African Republic. Trans R Soc Trop Med Hyg 1993; 87:530-5.